A new research at the Rockefeller University has shown that HIV can be suppressed by combining three antibodies in the treatment. This checks the ability of the virus to escape the immune system and mutate.
Medicine January 28, 2017
Heart health is compromised when atherosclerosis, or arterial hardening, is present. Researchers, however, have found that anti-cancer antibodies may be used to control plaque buildup.
Healthy Living/Wellness July 22, 2016
A simple blood test that looks into the levels of protective IgG antibodies can reveal a person's risks of suffering from a heart attack within five years. The findings can lead to new methods for preventing heart problems among high-risk individuals.
Healthy Living/Wellness June 20, 2016
In a large, national study employing desensitization, doctors successfully altered the immune systems of patients to enable them to accept kidneys from incompatible donors. This breakthrough is believed to shorten the waiting lists for kidney transplants and give hope to patients.
Life March 10, 2016
Ebola may be out of the public focus right now, but researchers are still hard at work studying how to combat the virus. With the discovery of new antibodies, they are a step closer to developing treatments against the virus.
Life February 22, 2016
Animals, today. Humans, tomorrow! Researchers successfully developed a vaccine that protected animals against the MERS virus, taking a step closer towards preventing the disease.
Life August 21, 2015
Scientists discovered an antibody for the dengue virus stereotype DENV-2, almost completing the puzzle to developing an anti-dengue vaccine. The scientists are further studying the development of the vaccine which incorporates antibodies of 4 dengue stereotypes – one which requires varying levels of protection.
Life July 6, 2015
A single drop of blood can reveal the entire history of a person's exposure to viruses, researchers say. A simple test can scan for thousands of viral strains people may have been exposed to over their lives.
Life June 4, 2015
The experimental Ebola vaccine dubbed cAd3-EBO triggered positive immune response in its first clinical trial involving 20 adults. Two of the volunteers had fever after vaccination, but no serious side effects were reported.
Life December 1, 2014